HBK Investments’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-18,959
Closed -$305K 795
2019
Q1
$305K Buy
+18,959
New +$307K ﹤0.01% 924
2018
Q4
Sell
-46,876
Closed -$852K 1292
2018
Q3
$852K Buy
46,876
+18,176
+63% +$318K 0.01% 782
2018
Q2
$484K Sell
28,700
-64,359
-69% -$1.22M ﹤0.01% 809
2018
Q1
$1.82M Buy
93,059
+46,161
+98% +$894K 0.01% 475
2017
Q4
$950K Buy
46,898
+7,678
+20% +$141K 0.01% 627
2017
Q3
$681K Buy
39,220
+4,420
+13% +$59.9K ﹤0.01% 723
2017
Q2
$446K Buy
+34,800
New +$465K ﹤0.01% 741
2016
Q1
Sell
-66,919
Closed -$1.16M 1020
2015
Q4
$1.16M Sell
66,919
-94,981
-59% -$1.51M 0.01% 535
2015
Q3
$2.17M Buy
161,900
+121,100
+297% +$2.43M 0.02% 394
2015
Q2
$921K Buy
40,800
+15,200
+59% +$267K 0.01% 583
2015
Q1
$366K Buy
+25,600
New +$369K ﹤0.01% 815
2014
Q3
Sell
-125,100
Closed -$1.24M 998
2014
Q2
$1.24M Buy
+125,100
New +$1.06M 0.03% 462

Other funds holding HALO

HBK Investments's HALO Position: Q2 2019 in Review

HBK Investments sold out of Halozyme (HALO) in Q2 2019, closing a stake of 18,959 shares — an estimated $305K sold.

HBK Investments first reported a position in HALO in Q2 2014 and held it in 12 quarters. The position peaked at $2.17M in Q3 2015. 202 funds tracked by Wall St. Rank hold HALO as of Q2 2019.

  • HBK Investments reported no remaining Halozyme position as of Q2 2019 after selling out during the quarter.
  • HBK Investments sold 18,959 Halozyme shares in Q2 2019, an estimated $305K.
  • HBK Investments first reported a position in Halozyme in Q2 2014 and held it in 12 quarters.
  • HBK Investments's Halozyme position peaked at $2.17M in Q3 2015.
  • 202 funds tracked by Wall St. Rank held Halozyme as of Q2 2019.

Based on HBK Investments's 13F filing for Q2 2019, filed 14 Aug 2019.